[1]谢玲玲,林仲秋*.妊娠期宫颈癌处理进展及临床争议[J].中国计划生育和妇产科,2019,(2):10-14.
点击复制

妊娠期宫颈癌处理进展及临床争议
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年2期
页码:
10-14
栏目:
综述
出版日期:
2019-02-25

文章信息/Info

作者:
谢玲玲; 林仲秋*
中山大学孙逸仙纪念医院妇产科
关键词:
妊娠; 宫颈癌; 诊断; 治疗
分类号:
R 737.33

参考文献/References:

［1］AMANT F, HALASKA M J, FUMAGALLI M A, et al. Gynecologic cancers in pregnancy guidelines of a second international consensus meeting ［J］. International Journal of Gynecological Cancer, 2014, 24(3): 394-403. ［2］HUNTER M I, MONK B J, TEWARI K S. Cervical neoplasia in pregnancy. Part 1: screening and management of preinvasive disease ［J］. American Journal of Obstetrics and Gynecology, 2008, 199 (1): 3-9. ［3］HUNTER M I, TEWARI K, MONK B J. Cervical neoplasia in pregnancy. Part 2: current treatment of invasive disease［J］. American Journal of Obstetrics and Gynecology, 2008, 199(1): 10-18. ［4］SOOD A K, SOROSKY J I, MAYR N, et al. Cervical cancer diagnosed shortly after pregnancy: prognostic variables and delivery routes ［J］. Obstetrics and Gynecology, 2000, 95(6 Pt 1): 832-838. ［5］Krrberg C, Rdberg T, Holmberg E, et al. Support for downstaging of pregnancyassociated cervical cancer［J］. Acta obstetricia et gynecologica Scandinavica, 2015, 94(6): 654-659. ［6］BORNSTEIN J, BENTLEY J, BSZE P, et al. 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy ［J］. Obstetrics and Gynecology, 2012, 120(1): 166-172. ［7］VAN CALSTEREN K, VERGOTE I, AMANT F. Cervical neoplasia during pregnancy: diagnosis, management and prognosis［J］. Best Practice & Research Clinical Obstetrics & Gynaecology, 2005, 19(4): 611-630. ［8］COLEMAN C A. Evaluation and management of abnormal cervical cytology during pregnancy ［J］. Clinical Obstetrics and Gynecology, 2013, 56(1): 51-54. ［9］JORDAN J, MARTIN-HIRSCH P, ARBYN M, et al. European guidelines for clinical management of abnormal cervical cytology, part 2 ［J］. Cytopathology : Official Journal of the British Society for Clinical Cytology, 2009, 20 (1): 5-16. ［10］American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology ［J］. Obstetrics and gynecology, 2008, 112(6): 1419-1444. ［11］MASSAD L S, EINSTEIN M H, HUH W K, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors ［J］. Journal of Lower Genital Tract Disease, 2013, 17(5 Suppl 1): S1-S27. ［12］BALLEYGUIER C, FOURNET C, BEN HASSEN W, et al. Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging ［J］. Clinical Imaging, 2012, 37(1): 70-76. ［13］ZANOTTI-FREGONARA P, LAFOREST R, WALLIS J W. Fetal radiation dose from 18F-FDG in pregnant patients imaged with PET, PET/CT, and PET/Mr［J］. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 2015, 56(8): 1218-1222. ［14］MORICE P, UZAN C, GOUY S, et al. Gynaecological cancers in pregnancy ［J］. The Lancet, 2012, 379 (9815): 558-569. ［15］TAKUSHI M, MOROMIZATO H, SAKUMOTO K, et al. Management of invasive carcinoma of the uterine cervix associated with pregnancy: outcome of intentional delay in treatment［J］. Gynecologic Oncology, 2002, 87(2): 185-189. ［16］GERMANN N, HAIE-MEDER C, MORICE P, et al. Management and clinical outcomes of pregnant patients with invasive cervical cancer ［J］. Annals of Oncology, 2005, 16(3): 397-402. ［17］VERCELLINO G F, KOEHLER C, ERDEMOGLU E, et al. Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome［J］. International Journal of Gynecological Cancer, 2014, 24(2): 364-371. ［18］KHLER C, OPPELT P, FAVERO G, et al. How much Platinum passes the placental barrier? Analysis of Platinum applications in 21 patients with cervical cancer during pregnancy［J］. American Journal of Obstetrics and Gynecology, 2015, 213(2): 206.e1-206.e5. ［19］DE HAAN J, VERHEECKE M, VAN CALSTEREN K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients［J］. The Lancet Oncology, 2018, 19(3): 337-346.

相似文献/References:

[1]阚滨,肖美霞.妊娠合并血小板减少症65例临床分析[J].中国计划生育和妇产科,2009,(05):0.
　KAN Bin,XIAO Mei-xia The department of gynaecology and obstetrics,Shengli hospital of Rugao city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(2):0.
[2]廖治,杨业洲.多发性硬化和妊娠[J].中国计划生育和妇产科,2009,(05):0.
[3]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
　FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[4]周萍,李秀美,江彩虹,等.妊娠合并卵巢肿瘤98例临床分析[J].中国计划生育和妇产科,2010,(02):0.
[5]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[6]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
　GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[7]莫丽芳.剖宫产手术中行子宫肌瘤剔除术体会[J].中国计划生育和妇产科,2010,(04):0.
　MO Li-fang Shilong Peoples hospital of Dongguan city,Dongguan Guangdong,China.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[8]何博.妊娠合并先天性心脏病的诊治研究进展[J].中国计划生育和妇产科,2010,(04):0.
[9]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
　XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(2):0.
[10]韩雪玲.妊娠期合并尖锐湿疣200例治疗方法比较[J].中国计划生育和妇产科,2011,(04):0.
　HAN Xue-ling.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.

更新日期/Last Update: 2019-02-25